Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Urticaria
ADR ID BADD_A04469
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.06      Urticarias
10.01.06.001      Urticaria
23      Skin and subcutaneous tissue disorders
23.04      Angioedema and urticaria
23.04.02      Urticarias
23.04.02.001      Urticaria
Description A disorder characterized by an itchy skin eruption characterized by wheals with pale interiors and well-defined red margins. [CTCAE] A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. [MeSH]
MedDRA Code 10046735
MeSH ID D014581
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute allergic urticaria | Acute urticaria | Allergic urticaria | Erythema urticarial | Generalised urticarial | Generalised urticarial rash | Histamine-like rash | Hives | Nettle rash | Other specified urticaria | Pharmacological urticaria | Rash urticaria-like | Rash urticarial | Subcutaneous urticaria | Unspecified urticaria | Urticaria | Urticaria acute | Urticaria aggravated | Urticaria NOS | Urticaria subcutaneous | Urticaria, unspecified | Urticarial | Urticarial rash | Urticarial symptom | Urticated rash | Urtication | Welts | Wheals | Generalized urticaria | Urticaria generalised | Urticaria drug-induced | Urticaria localised | Urticaria localized | Generalized urticarial rash | Urticaria recurrent | Generalised urticaria | Atopic urticaria | Urticarias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01470Minocycline0.004227%
BADD_D01471Minocycline anion--
BADD_D01472Minocycline hydrochloride--
BADD_D01475Mirabegron--
BADD_D01476Mirtazapine--
BADD_D01477Misoprostol0.001541%
BADD_D01480Mitoxantrone--
BADD_D01481Mitoxantrone hydrochloride--
BADD_D01482Mivacurium chloride--
BADD_D01483Moclobemide--
BADD_D01484Modafinil0.001235%
BADD_D01485Moexipril hydrochloride--
BADD_D01486Moexiprilat--
BADD_D01490Mometasone0.000297%
BADD_D01496Montelukast0.000374%
BADD_D01497Montelukast sodium--
BADD_D01498Morphine0.035955%
BADD_D01499Morphine sulfate--
BADD_D01500Morphine tincture--
BADD_D01501Moxifloxacin0.000431%
BADD_D01502Moxifloxacin hydrochloride--
BADD_D01503Moxonidine--
BADD_D01504Mupirocin--
BADD_D01505Mupirocin calcium--
BADD_D01506Muromonab-cd3--
BADD_D01507Mycophenolate mofetil--
BADD_D01509Myristyl sulfate--
BADD_D01511Nabumetone0.000468%
BADD_D01513Nafarelin--
BADD_D01514Nafarelin acetate--
The 28th Page    First    Pre   28 29 30 31 32    Next   Last    Total 45 Pages
ADReCS-Target
ADR Term Drug Name Target